Clinical Role - Hospital
Pharmacy Times® is at the forefront of providing the latest clinical updates, patient counseling tools and innovative solutions to hospital pharmacists and reaches more than 200,000 pharmacy professionals in total.
Glenmark Pharmaceuticals has received FDA approval for abiraterone acetate tablets USP, 250 mg, a generic of Janssen's Zytiga tablets, 250 mg.1
Potential clinical and financial causes for hesitation in the transition to subcutaneous dosing are addressed.
Kyowa Kirin’s istradefylline (Nourianz) is now available in the United States as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) that are experiencing “off” episodes.
Top news of the day from across the health care landscape.
Experts provide perspective on how they prepare their staff for the transition to subcutaneous dosing.
Today is National Pharmacy Technician Day, and pharmacists are sharing how valuable technicians are to them.
In the wake of California’s drug transparency law, an analysis by state health officials on pricing trends found that drug companies raised the whole acquisition cost dramatically for many drugs.
The Rite Aid Foundation is awarding $2.3 million to Children’s Miracle Network Hospitals through its KidCents Grant Program.
To date, the FDA has granted rivaroxaban 8 indications, 6 of which are specifically for the treatment, prevention, and reduction in the risk of recurrence of venous thromboemolism across a wide range of patient populations.
A researcher at the Washington University School of Medicine in St.Louis has received close to $7.5 million in total funding for research towards development of stem cell-based treatments for chronic pulmonary disease (COPD), asthma, and other disorders.
Top news of the week from Specialty Pharmacy Times.
This article is the third in a series on difficult to pronounce drug names.
+ Load More